Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Key Moments:

  • XRP’s price fell by 2.95% to $2.17805 on Friday.
  • Open interest declined by 4%.
  • Large-scale investor sell-offs of $600 million contributed significantly to the price drop.

Market Turbulence Hits XRP

The price of XRP experienced a sharp decline on Friday as it sank almost 3% and fell from the $2.20 threshold. An earlier dip even saw the price briefly sink to around $2.14 as widespread liquidations impacted the digital asset sector. Thin trading volumes and a slowdown in XRP Ledger activity contributed further to the bearish sentiment surrounding the token.

XRP down almost 3%, TradingView

Whale Activity Sparks Volatility

Downward pressure was further intensified by a wave of selling, forcing market participants to reassess their positions. Total liquidations topped $600 million, and analysts believe that large-scale investors, often referred to as “whales,” were responsible for tipping the balance. According to analyst Block Bull, these players appeared to take advantage of declining prices to acquire XRP at reduced costs.

XRP’s downward movement signals broader instability in the cryptocurrency market, with other digital assets, such as Cardano, also reacting to the same macroeconomic triggers. Concerns surrounding future Federal Reserve monetary policy decisions, as well as the ongoing legal proceedings surrounding the SEC versus Ripple case, also played a role in market dynamics. While Ripple’s leadership, including CEO Brad Garlinghouse, has not publicly commented on the current conditions, market participants remain alert to upcoming regulatory shifts and their implications.

Market indicators pointed to a deteriorating outlook, with open interest sliding by a notable 4%. According to analysts, it is possible for XRP’s price to drop further by 30% based on historical models. They did not rule out a potential recovery, however.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: GBP/USD daily trading forecastForex Market: GBP/USD daily trading forecast Yesterday’s trade saw GBP/USD within the range of 1.5601-1.5746. The pair closed at 1.5637, losing 0.49% on a daily basis.At 7:56 GMT today GBP/USD was up 0.14% for the day to trade at 1.5657. The pair touched a daily high at […]
  • EUR/USD hits one-week highs on PBOC Governor remarksEUR/USD hits one-week highs on PBOC Governor remarks EUR/USD hit a one-week high after the statement of the Governor of Peoples Bank of China (PBOC), Zhou Xiaochuan, made in Beijing earlier today.The EUR/USD reached a session high at 1.3571 at 8:25 GMT, gaining 0.39% on a daily basis. […]
  • Carlyle Group to acquire minority stake in Quest GlobalCarlyle Group to acquire minority stake in Quest Global According to a Reuters report, citing sources with knowledge of the matter, Carlyle Group has agreed to acquire a minority stake in Singapore-based Quest Global Services, which values the latter at $2 billion.The transaction is to be […]
  • Forex Market: GBP/USD daily trading outlookForex Market: GBP/USD daily trading outlook Friday’s trade saw GBP/USD within the range of 1.4600-1.4693. The pair closed at 1.4625, shedding 0.31% on a daily basis. It has been the 27th drop in the past 46 trading days and also a second consecutive one. The daily low has been an almost […]
  • United States Steel shares slump after forecast for second-quarter lossesUnited States Steel shares slump after forecast for second-quarter losses Shares in United States Steel Corp. declined 14% in premarket Thursday trading. The reason for that was the company’s forecast for second-quarter losses that surpassed analysts’ expectations.Early on Monday, the company announced its […]
  • Roche share price up, the FDA approves its Ebola test for emergency useRoche share price up, the FDA approves its Ebola test for emergency use Roche Holding AG announced that its Ebola test virus got approved by US health regulators and it would be used in emergencies to fight the deadly disease outbreak in West Africa.The Swiss drugmaker said that the US Food and Drug […]